These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 34365576)

  • 21. Extracellular Vesicles in CNS Developmental Disorders.
    Gomes AR; Sangani NB; Fernandes TG; Diogo MM; Curfs LMG; Reutelingsperger CP
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomes: Current use and future applications.
    Chung IM; Rajakumar G; Venkidasamy B; Subramanian U; Thiruvengadam M
    Clin Chim Acta; 2020 Jan; 500():226-232. PubMed ID: 31678573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain.
    Pegtel DM; Peferoen L; Amor S
    Philos Trans R Soc Lond B Biol Sci; 2014 Sep; 369(1652):. PubMed ID: 25135977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crossing the Blood-Brain Barrier: A Review on Drug Delivery Strategies for Treatment of the Central Nervous System Diseases.
    Mansor NI; Nordin N; Mohamed F; Ling KH; Rosli R; Hassan Z
    Curr Drug Deliv; 2019; 16(8):698-711. PubMed ID: 31456519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies for delivering therapeutics across the blood-brain barrier.
    Terstappen GC; Meyer AH; Bell RD; Zhang W
    Nat Rev Drug Discov; 2021 May; 20(5):362-383. PubMed ID: 33649582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Exosomes in Central Nervous System Diseases.
    Liu W; Bai X; Zhang A; Huang J; Xu S; Zhang J
    Front Mol Neurosci; 2019; 12():240. PubMed ID: 31636538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomes: a new weapon to treat the central nervous system.
    Braccioli L; van Velthoven C; Heijnen CJ
    Mol Neurobiol; 2014 Feb; 49(1):113-9. PubMed ID: 23857502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine?
    Aryani A; Denecke B
    Mol Neurobiol; 2016 Mar; 53(2):818-834. PubMed ID: 25502465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular vesicles for the treatment of central nervous system diseases.
    Gratpain V; Mwema A; Labrak Y; Muccioli GG; van Pesch V; des Rieux A
    Adv Drug Deliv Rev; 2021 Jul; 174():535-552. PubMed ID: 33991589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applications of stem cell-derived exosomes in tissue engineering and neurological diseases.
    Sun B; Peng J; Wang S; Liu X; Zhang K; Zhang Z; Wang C; Jing X; Zhou C; Wang Y
    Rev Neurosci; 2018 Jul; 29(5):531-546. PubMed ID: 29267178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exosomes as drug delivery vehicles and biomarkers for neurological and auditory systems.
    Mittal R; Bencie N; Langlie J; Mittal J; Eshraghi AA
    J Cell Physiol; 2021 Dec; 236(12):8035-8049. PubMed ID: 34224589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease.
    Qu M; Lin Q; Huang L; Fu Y; Wang L; He S; Fu Y; Yang S; Zhang Z; Zhang L; Sun X
    J Control Release; 2018 Oct; 287():156-166. PubMed ID: 30165139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications of nanotechnology in drug delivery to the central nervous system.
    Saeedi M; Eslamifar M; Khezri K; Dizaj SM
    Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
    Kanazawa T
    Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular vesicles in the diagnosis and treatment of central nervous system diseases.
    Shaimardanova AA; Solovyeva VV; Chulpanova DS; James V; Kitaeva KV; Rizvanov AA
    Neural Regen Res; 2020 Apr; 15(4):586-596. PubMed ID: 31638080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomes: A Novel Therapeutic Paradigm for the Treatment of Depression.
    Bhatt S; Kanoujia J; Dhar AK; Arumugam S; Silva AKA; Mishra N
    Curr Drug Targets; 2021; 22(2):183-191. PubMed ID: 33023431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers.
    Mulvihill JJ; Cunnane EM; Ross AM; Duskey JT; Tosi G; Grabrucker AM
    Nanomedicine (Lond); 2020 Jan; 15(2):205-214. PubMed ID: 31916480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain.
    Yuan D; Zhao Y; Banks WA; Bullock KM; Haney M; Batrakova E; Kabanov AV
    Biomaterials; 2017 Oct; 142():1-12. PubMed ID: 28715655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.